Cargando…
PCSK9 Inhibitors: What Lies Beyond Monoclonal Antibodies?
Autor principal: | EBioMedicine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703719/ https://www.ncbi.nlm.nih.gov/pubmed/26844247 http://dx.doi.org/10.1016/j.ebiom.2015.12.006 |
Ejemplares similares
-
2014: A Year of Breakthroughs for Translational Science
por: EBioMedicine
Publicado: (2014) -
The Tumor Microenvironment: A Druggable Target for Metastatic Disease?
por: EBioMedicine
Publicado: (2018) -
EBioMedicine: Translating Science to Improve Health
por: EBioMedicine
Publicado: (2018) -
Targeted Protein Degradation: Unlocking the Therapeutic Proteome
por: EBioMedicine
Publicado: (2018) -
The maternal microbiome: another bridge linking mothers and infants
por: EBioMedicine
Publicado: (2021)